Benevolence is a modern hybrid strain with an enigmatic background, as its precise origins remain undocumented and the full scope of its genetic lineage is not publicly confirmed beyond its connection to Mendodawg. Because the history of this cultivar is thinly recorded, there is no official narrative regarding its breeding or the specific intentions behind its creation. This lack of clear documentation is a defining feature of the strain, distinguishing it from varieties with well-mapped pedigrees while leaving its development story largely to speculation.

The sensory profile of Benevolence is anchored by a confirmed terpene sequence that begins with caryophyllene and proceeds through limonene, myrcene, humulene, beta-pinene, pinene, bisabolol, and linalool. This complex arrangement of secondary metabolites suggests an aromatic profile defined by the interplay between spice, citrus, and subtle herbal undertones. While the cannabinoid content is not batch-specific, the strain maintains an estimated THC concentration of approximately 20.4 percent, with negligible levels of CBD. These chemical constituents work in concert to provide a consistent baseline for the user experience.

In practice, Benevolence delivers effects characterized by states of relaxation, happiness, and an uplifted mood. It serves as an effective tool for those seeking assistance with stress, pain, or the facilitation of sleep. Cultivators who choose to work with this variety will find it to be of moderate difficulty, capable of thriving in both indoor and outdoor environments. With a flowering period of 60 days, the plant is noted for its high yield. As of current records, there are no documented offspring resulting from this strain.